Foley attorneys Lena Robins, Robert Slavkin, and Heidi Sorensen will be speaking March 11-12, 2008 at the Medicaid Drug Rebate Program in Miami, Florida.
Ms. Robins is speaking on March 11, 2008 from 9:05 a.m. – 10:05 a.m. Her session is titled “The Final AMP and Best Price Rule: Sense of the New Requirements.” This session will discuss in detail CMS’ final AMP and Best Price rule, which went into effect on October 1, 2007 — including issues related to the key definitions, manufacturer reporting obligations, determination and calculation of AMP and Best Price, pharmacy reimbursement issues, fraud and abuse implications, unresolved issues, and future issues.
Ms. Sorensen is speaking on March 11, 2008 from 11:15 a.m. – 12:15 p.m. Her session is titled “Understanding the Focus of Enforcers in Healthcare Fraud.” Get an insider’s point of view as former chief in the Administration & Civil Remedies Branch of the Office of Counsel to the Inspector General focuses on understanding healthcare fraud investigations. The session will also provide insight into the process the government uses in resolving cases. While aspects of the government’s investigative and case resolution process are common across the healthcare industry, the session will also cover aspects of the government’s investigations unique to pharmaceutical manufacturers.
Some topics that will be covered include:
- Understanding the roles of OIG, CMS, DOJ, state Medicaid Fraud Control Units, and their law enforcement partners
- Anatomy of an investigation
- DOJ’s use of parallel criminal/civil investigations and deferred prosecution agreements
- What to do if the enforcers show up
- Case resolutions
- Question and answer session
Mr. Slavkin is speaking on March 11, 2008 from 4:30 p.m. – 5:30 p.m. His session is titled “Implementation of an Effective Compliance Program.” This session will cover the ins and outs of implementing an effective compliance program. Topics will include:
- Recognizing an effective compliance program: The elements of creation of a compliance program that has longevity within your organization. Discussion will include incorporation of the OIG’s guidance on the seven elements to include in a compliance program
- Impact of ineffective compliance programs: Identify common deficiencies found in compliance programs and the impact these deficiencies may have on your organization.
- Keeping your compliance program operating effectively: Strategies to be utilized that help to ensure a compliance program that has a positive impact on your organization. Discussion will include buy-in from ‘the top,’ appropriate initial and ongoing training and education, and crafting appropriate internal auditing and monitoring tools.
- Application of the OIG guidance on a Part D compliance program: Part D Marketing Guidelines, as well as Part D compliance generally, and how a compliance program can be modified to include Part D compliance.
To register, please contact Michael Russo at 201.662.3199.